Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.

doi:10.1186/s12931-022-02275-4

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.

Respiratory research - 16 Dec 2022

Miravitlles Marc, Turner Alice M, Torres-Duran María, Tanash Hanan, Rodríguez-García Carlota, López-Campos José Luis, Chlumsky Jan, Guimaraes Catarina, Rodríguez-Hermosa Juan Luis, Corsico Angelo, Martinez-González Cristina, Hernández-Pérez José María, Bustamante Ana, Parr David G, Casas-Maldonado Francisco, Hecimovic Ana, Janssens Wim, Lara Beatriz, Barrecheguren Miriam, González Cruz, Stolk Jan, Esquinas Cristina, Clarenbach Christian F

Abstract excerpt

BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) is a rare disease that is associated with an increased risk of pulmonary emphysema. The European AATD Research Collaboration (EARCO) international registry was founded with the objective of characterising the individuals with AATD and investigating their natural history. METHODS: The EARCO registry is an international, observational and prospective study of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to alpha 1-Antitrypsin Deficiency

Share to Bronchiectasis

Share to Cross-Sectional Studies

Share to Genotype

Share to Pulmonary Disease, Chronic Obstructive

Share to Pulmonary Emphysema

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 36527073
DOI: 10.1186/s12931-022-02275-4
PMCID: PMC9756677

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.PMID 36527073Read ↗

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: Initial report of EARCOSemantic proximity Read ↗

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.Semantic proximity Read ↗

Alpha-1 Antitrypsin Genotype Distribution in Patients with Emphysema.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency in bronchiectasis: Evidence for an overlooked entity beyond COPD: A retrospective observational study.Semantic proximity Read ↗

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicineSemantic proximity Read ↗

Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation.Semantic proximity Read ↗

Alpha1-antitrypsin deficiency: a clinical-genetic overviewSemantic proximity Read ↗

The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes.Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

α1-Antitrypsin deficiency and chronic respiratory disorders.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.